Nurix Therapeutics (NRIX) Other Non-Current Liabilities (2019 - 2021)

Nurix Therapeutics (NRIX) has 3 years of Other Non-Current Liabilities data on file, last reported at $796000.0 in Q3 2021.

• On a quarterly basis, Other Non-Current Liabilities fell 8.29% year-over-year to $796000.0 in Q3 2021; TTM through Aug 2021 was $796000.0, a 8.29% decrease from a year earlier, with the FY2020 full-year figure at $850000.0, down 51.07% from the prior year.
• Other Non-Current Liabilities for Q3 2021 stood at $796000.0, down from $837000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for NRIX reached as high as $1.7 million in Q4 2019 and fell as low as $796000.0 in Q3 2021.
• Historically, Other Non-Current Liabilities has averaged $986666.7 across 3 years, with a median of $843500.0 in 2020.
• Across the five-year window, Other Non-Current Liabilities tumbled 51.07% in 2020 and fell 8.29% in 2021, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.7 million in 2019, then plunged by 51.07% to $850000.0 in 2020, then dropped by 6.35% to $796000.0 in 2021.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $796000.0 in Q3 2021, $837000.0 in Q2 2021, and $832000.0 in Q1 2021.